Neurotech Pharmaceuticals Co., Ltd.
Records under this name other than the patents Neurotech Pharmaceuticals Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Neurotech Pharmaceuticals Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,455,470 | Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,608,585 | Compositions for inhibition of necrosis induced by a neurotrophin Formerly held Term ended Term ended Feb 8, 2025 · From the USPTO record | Term ended | Term ended Feb 8, 2025 | From the USPTO record |
| US 7,371,896 | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same Term ended Term ended Aug 1, 2023 · From the USPTO record | Term ended | Term ended Aug 1, 2023 | From the USPTO record |
| US 6,927,303 | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same Term ended Term ended Jun 19, 2023 · From the USPTO record | Term ended | Term ended Jun 19, 2023 | From the USPTO record |
| US 7,189,878 | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same Term ended Term ended Jun 19, 2023 · From the USPTO record | Term ended | Term ended Jun 19, 2023 | From the USPTO record |
| US 7,319,160 | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same Term ended Ended no later than Jun 19, 2023 · From the USPTO record | Term ended | Ended no later than Jun 19, 2023 | From the USPTO record |
| US 7,511,074 | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same Term ended Term ended Jun 19, 2023 · From the USPTO record | Term ended | Term ended Jun 19, 2023 | From the USPTO record |
| US 7,750,045 | Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system Term ended Term ended Apr 9, 2023 · From the USPTO record | Term ended | Term ended Apr 9, 2023 | From the USPTO record |
| US 7,422,874 | Expression vector for animal cell Formerly held Term ended Term ended Dec 21, 2022 · From the USPTO record | Term ended | Term ended Dec 21, 2022 | From the USPTO record |
| US 7,259,010 | Expression vector for animal cell containing nuclear matrix attachment region of interferon beta Formerly held Term ended Term ended Jul 17, 2022 · From the USPTO record | Term ended | Term ended Jul 17, 2022 | From the USPTO record |